Biogen inc stock.

RBC Ups Target on Biogen to $357 From $354, Maintains Outperform Rating Aug. 29: MT Mizuho Adjusts Biogen's Price Target to $335 From $340, Keeps Buy Rating Aug. 14: MT TD Cowen Cuts Biogen Price Target to $305 From $315, Maintains Outperform RatingNov 30, 2023 · As of November 30, 2023, Biogen Inc had a $33.6 billion market capitalization, putting it in the 95th percentile of companies in the Pharmaceuticals industry. Currently, Biogen Inc’s price-earnings ratio is 23.3. Biogen Inc’s trailing 12-month revenue is $10.0 billion with a 14.6% profit margin. See the latest Biogen Inc stock price (BIIB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.

Oct 31, 2023 · Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.

Nikkei 225. 33,447.67. -0.53%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Biogen Inc (BIIB.OQ) real-time stock quotes, news, price and financial information from Reuters to ...

Biogen Stock Forecast 12-09-2023. Forecast target price for 12-09-2023: $ 231.10. Negative dynamics for Biogen shares will prevail with possible volatility of 3.064%. Pessimistic target level: 225.90. Optimistic target level: 233.04.Bought 300.1 Thousand shares of Biogen Inc: 9/30/2023: VAN ECK ASSOCIATES CORP. Bought 233.9 Thousand shares of Biogen Inc: 9/29/2023: ... Most stock quote data provided by BATS. Market indices ...How much is Biogen Inc stock worth? Invest confidently with precise valuations ... Is Biogen Inc stock a buy? Gain a strategic edge with ratings and sectors ...Biogen Company Info. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.

The Biogen Inc. stock price gained 0.87% on the last trading day (Thursday, 30th Nov 2023), rising from $232.06 to $234.08.During the last trading day the stock fluctuated 2.56% from a day low at $229.24 to a day high of $235.11.The price has been going up and down for this period, and there has been a 1.94% gain for the last 2 …

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (80.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (15.1%) ; - other (4.4%): primarily ...

RBC Ups Target on Biogen to $357 From $354, Maintains Outperform Rating Aug. 29: MT Mizuho Adjusts Biogen's Price Target to $335 From $340, Keeps Buy Rating Aug. 14: MT TD Cowen Cuts Biogen Price Target to $305 From $315, Maintains Outperform RatingThe Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.Biogen Stock Performance. Shares of Biogen stock opened at $234.64 on Friday. The company has a current ratio of 1.68, a quick ratio of 1.09 and a debt-to-equity ratio of 0.47. The firm has a ...As of November 30, 2023, Biogen Inc had a $33.6 billion market capitalization, putting it in the 95th percentile of companies in the Pharmaceuticals industry. Currently, Biogen Inc’s price-earnings ratio is 23.3. Biogen Inc’s trailing 12-month revenue is $10.0 billion with a 14.6% profit margin.The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...Biogen stock ( BIIB) is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the company's new Alzheimer's drug in partnership with Japan’s Eisai ...

Biogen Inc. Common Stock (BIIB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Biogen Inc (BIIB) stock has risen 2.66% while the S&P 500 has fallen -0.49% as of 11:16 AM on Wednesday, Apr 5. BIIB has gained $7.31 from the previous closing price of $275.25 on volume of 296,402 shares. Over the past year the S&P 500 is lower by -9.83% while BIIB has gained 36.10%. BIIB earned $20.87 a per share in the over the last 12 ...December 3, 2023. Polar Capital Holdings Plc lifted its position in Biogen Inc. ( NASDAQ:BIIB - Free Report) by 30.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the biotechnology company's stock after acquiring an additional 75,000 shares during the ...Jul 28, 2023 · Biogen to host investor conference call today at 9:00 a.m. ET. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share ... Biogen Inc. is a global biotechnology company. The Company is focused on discovering, developing and delivering therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease.Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformation. CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Monish Patolawala, currently President and Chief Financial Officer of 3M …

William Hawkins biography. William A. Hawkins III serves as Independent Director of the Company. Mr. Hawkins serves as a Senior Advisor to EW Healthcare Partners, a life sciences private equity firm. Mr. Hawkins is the former Chairman and Chief Executive Officer of Medtronic, Inc., a global leader in medical technology.

December 3, 2023. Polar Capital Holdings Plc lifted its position in Biogen Inc. ( NASDAQ:BIIB - Free Report) by 30.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the biotechnology company's stock after acquiring an additional 75,000 shares during the ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...May 12, 2023 · 3. Biogen's beaten-up valuation gives investors a buffer. Shares of Biogen currently trade at a modest 13 times earnings. By comparison, the average healthcare stock trades at a multiple of 24 ... ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementia. CAMBRIDGE, Mass. and TOKYO, July 08, 2021 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced the U.S. Food and Drug Administration (FDA) has approved an …Biogen Inc. (BIIB) stock forecast and price target. Find the latest Biogen Inc. BIIB analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Biogen Inc. (BIIB) closed at $262.37 in the latest trading session, marking a +0.01% move from the prior day. This change outpaced the S&P 500's 0.7% loss on the day. Meanwhile, the Dow lost 0.87% ...Pursuant to the Biogen Inc. 2017 Omnibus Equity Plan (as it may be amended from time to time, the “Plan”), Biogen Inc. (the “Company”) hereby grants to you, an employee of the Company or one of its Affiliates (the “Participant”), on each of the grant dates specified on your Fidelity stock plan account (the “Grant Date”), the number of restricted stock units …With its stock down 11% over the past month, it is easy to disregard Biogen (NASDAQ:BIIB). But if you pay close attention, you might find that its key financial indicators look quite decent, which ...Get the latest Biogen Inc (IDP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Nov 30, 2023 · Complete Biogen Inc. stock information by Barron's. View real-time BIIB stock price and news, along with industry-best analysis.

Nov 27, 2023 · Get Biogen Inc (BIIB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ... Biogen Inc BIIB.O. Official Data Partner. Latest Trade ...

Dec 21, 2022 · Biogen Inc. (BIIB) closed at $286.86 in the latest trading session, marking a -0.23% move from the prior day. This move lagged the S&P 500's daily gain of 1.49%.

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily revenues …( BIIB | USA). Beta is a statistical measure that compares the volatility of a stock against the volatility of the broader market, which is typically measured ...Biogen Inc. (BIIB) Stock Moves -0.19%: What You Should Know. Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy? Alector (ALEC) Up 7% on Finishing Enrolment in Alzheimer Study. The Zacks Analyst Blog Highlights Humana, Cintas, Biogen, Royal Caribbean Cruises and Markel Group. Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.The low in the last 52 weeks of Biogen stock was 220.86. According to the current price, Biogen is 108.22% away from the 52-week low. What was the 52-week high for Biogen stock? Tracfone Wireless Inc has been a leading player in the telecommunications industry, offering innovative solutions and cutting-edge technology to its customers. With a focus on providing reliable and affordable wireless services, Tracfone ha...Dec 21, 2022 · Biogen Inc. (BIIB) closed at $286.86 in the latest trading session, marking a -0.23% move from the prior day. This move lagged the S&P 500's daily gain of 1.49%. How much is Biogen stock worth today? ( NASDAQ: BIIB) Biogen currently has 144,898,112 outstanding shares. With Biogen stock trading at $231.95 per share, the total value of Biogen stock (market capitalization) is $33.61B. Biogen stock was originally listed at a price of $5.73 in Dec 31, 1997.

Mar 21, 2023 · Biogen Inc. (BIIB Quick Quote BIIB - Free Report) closed the most recent trading day at $266.15, moving -0.66% from the previous trading session.This change lagged the S&P 500's 1.3% gain on the day. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of …Jul 28, 2023 · Biogen to host investor conference call today at 9:00 a.m. ET. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals, Inc ... Instagram:https://instagram. m m csolar integratedhotstar subscriberswhy is tesla stock falling Biogen Inc. (BIIB) closed the most recent trading day at $276.17, moving -0.8% from the previous trading session. This change lagged the S&P 500's 0.71% gain on the day. Meanwhile, the Dow gained ...Biogen Inc. stock underperforms Tuesday when compared to competitors 11/28/23-4:01AM EST MarketWatch Biogen Inc. stock falls Monday, underperforms market 11/27/23-4:00AM EST MarketWatch. best cash managementsilver price future prediction Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science … financial advisors bozeman mt Biogen Inc. (BIIB) delivered earnings and revenue surprises of 6.63% and 3.32%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Biogen shares were off about 4% at $277.10 in morning trading. Biogen sales are expected to decline by mid-single digit percentages in 2023 after they fell nearly 7% to $2.54 billion in the fourth ...Related Stocks ... Adicet Bio, Inc. ... Seagen, Inc. ... Intellia Therapeutics Inc. ... When you invest, your capital is at risk. The value of investments can go up as ...